A detailed history of Verus Financial Partners, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Verus Financial Partners, Inc. holds 9,517 shares of PFE stock, worth $271,520. This represents 0.03% of its overall portfolio holdings.

Number of Shares
9,517
Previous 10,204 6.73%
Holding current value
$271,520
Previous $283,000 6.01%
% of portfolio
0.03%
Previous 0.03%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 05, 2024

SELL
$25.26 - $29.6 $17,353 - $20,335
-687 Reduced 6.73%
9,517 $266,000
Q4 2023

Feb 06, 2024

SELL
$26.13 - $33.94 $20,799 - $27,016
-796 Reduced 7.24%
10,204 $293,000
Q3 2023

Oct 23, 2023

BUY
$32.09 - $37.51 $12,258 - $14,328
382 Added 3.6%
11,000 $364,000
Q2 2023

Jul 27, 2023

SELL
$36.12 - $41.79 $172,834 - $199,965
-4,785 Reduced 31.07%
10,618 $389,000
Q1 2023

May 05, 2023

SELL
$39.39 - $51.28 $24,973 - $32,511
-634 Reduced 3.95%
15,403 $628,000
Q4 2022

Feb 01, 2023

SELL
$41.75 - $54.5 $751 - $981
-18 Reduced 0.11%
16,037 $822,000
Q3 2022

Oct 31, 2022

SELL
$43.76 - $53.42 $10,852 - $13,248
-248 Reduced 1.52%
16,055 $708,000
Q2 2022

Aug 03, 2022

BUY
$46.53 - $55.17 $30,011 - $35,584
645 Added 4.12%
16,303 $833,000
Q1 2022

Apr 15, 2022

BUY
$45.75 - $56.69 $10,659 - $13,208
233 Added 1.51%
15,658 $832,000
Q4 2021

Jan 19, 2022

BUY
$41.32 - $61.25 $41 - $61
1 Added 0.01%
15,425 $911,000
Q3 2021

Oct 29, 2021

BUY
$39.25 - $50.42 $5,966 - $7,663
152 Added 1.0%
15,424 $637,000
Q2 2021

Jul 23, 2021

SELL
$35.91 - $40.68 $10,521 - $11,919
-293 Reduced 1.88%
15,272 $627,000
Q1 2021

Apr 27, 2021

BUY
$33.49 - $37.77 $167 - $188
5 Added 0.03%
15,565 $559,000
Q4 2020

Feb 10, 2021

SELL
$33.47 - $42.56 $384,336 - $488,716
-11,483 Reduced 42.46%
15,560 $573,000
Q3 2020

Nov 03, 2020

BUY
$31.75 - $37.25 $385,540 - $452,326
12,143 Added 81.5%
27,043 $992,000
Q2 2020

Jul 31, 2020

SELL
$30.12 - $36.54 $572 - $694
-19 Reduced 0.13%
14,900 $487,000
Q1 2020

Apr 09, 2020

BUY
$27.03 - $38.62 $4,784 - $6,835
177 Added 1.2%
14,919 $487,000
Q4 2019

Jan 21, 2020

BUY
$32.92 - $37.36 $5,859 - $6,650
178 Added 1.22%
14,742 $578,000
Q3 2019

Oct 15, 2019

SELL
$32.49 - $42.13 $162 - $210
-5 Reduced 0.03%
14,564 $523,000
Q2 2019

Aug 05, 2019

BUY
$36.98 - $41.52 $145,072 - $162,882
3,923 Added 36.85%
14,569 $631,000
Q1 2019

Apr 19, 2019

BUY
$37.5 - $41.2 $13,200 - $14,502
352 Added 3.42%
10,646 $452,000
Q3 2018

Nov 09, 2018

BUY
$34.47 - $41.81 $34 - $41
1 Added 0.01%
10,294 $454,000
Q2 2018

Jul 16, 2018

BUY
$32.98 - $35.16 $32 - $35
1 Added 0.01%
10,293 $373,000
Q1 2018

Apr 23, 2018

BUY
$31.91 - $37.02 $31 - $37
1 Added 0.01%
10,292 $365,000
Q4 2017

Jan 29, 2018

BUY
$33.26 - $35.29 $33 - $35
1 Added 0.01%
10,291 $373,000
Q3 2017

Nov 03, 2017

BUY
$31.0 - $34.15 $318,990 - $351,403
10,290
10,290 $367,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $160B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Verus Financial Partners, Inc. Portfolio

Follow Verus Financial Partners, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verus Financial Partners, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Verus Financial Partners, Inc. with notifications on news.